Charles W. Newton is CFO at Lyell Immunopharma, Inc. (LYEL). They have made 3 open-market trades across 1 company since 2025, most recently 2026-08-18.
CIK 0001866219
1 open-market purchase totalling $224K since 2025, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KROS | SELL · 10b5-1 | 2026-08-18 | 2026-08-20 | $10.30 | $6K | +0.3% | +4.8% | — |
| KROS | SELL · 10b5-1 | 2026-06-11 | 2026-06-15 | $10.04 | $6K | +7.8% | +8.4% | +10.2% |
| LYEL | SELL | 2025-08-21 | 2025-08-22 | $10.54 | $15K | +8.9% | +22.4% | +62.0% |
| LYEL | SELL | 2025-08-11 | 2025-08-13 | $10.43 | $3K | +4.3% | +21.9% | +64.0% |
| LYEL | BUY | 2025-03-17 | 2025-03-18 | $0.56 | $224K | +0.2% | -19.7% | -5.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.